Beasley, Allen, Crow, Methvin, Portis & Miles, P.C.

A study by a group of Italian researchers shows that virtual colonoscopies that use computer tomography scans are almost as effective at detecting tumors and precancerous lesions as standard colonoscopies, which requires threading a camera through the colon. The study, published in The Journal of the American Medical Association, suggests that the new procedure may offer an alternative to people who are too embarrassed or afraid to undergo a standard colonoscopy.

Read the rest of this entry »

Nobody enjoys colonoscopies, but they save lives. Regular colon screenings can detect polyps even before they become cancerous. It is recommended that people begin colon screenings beginning at age 50, or earlier if they have a family history or are exhibiting symptoms such as blood in the stool. But how can you convince someone he needs to have a colonoscopy? Just have Pauly Polyp do the asking.

Read the rest of this entry »

The Food and Drug Administration (FDA) black box warning on oral sodium phosphates (OSPs) came late last year, but as early as 2003, doctors were beginning to make the link between OSP pills and solutions used to clear the bowel before colonoscopies and serious and permanent kidney injuries. As more and more reports of kidney damage and even complete kidney failure began to pour in to the FDA, the agency finally issued a mild warning in 2005. The black box warning on prescription OSP products would come three years later, after 21 more reports of serious kidney injuries. Soon after that FDA warning, C.B. Fleet quickly pulled its over-the-counter OSP products off the market.

Read the rest of this entry »

Could samples of your stool keep you from having a colonoscopy? Researchers at Baylor Medical Center think so. A team of doctors from Baylor pored through stool samples, analyzed long strands of DNA and were able to diagnose gastrointestinal cancers early, according to a report from KARE-TV 11.

Read the rest of this entry »

Colorectal cancer, or cancers of the colon or rectum, is the third most common cancer diagnosed in both men and women and the second leading cause of cancer-related deaths in the United States among men and women combined, according to the American Cancer Society. The average person has about a 1 in 19 risk of developing the disease over his lifetime. Detected early, the disease can be curable. The best defense is regular screenings. Regular colonoscopies are recommended beginning at age 50, or sooner for those with a family history or exhibiting symptoms.

Read the rest of this entry »

Clinical trials of a vaccine designed to trigger the body to attack a protein linked to colon cancer are currently being conducted by scientists at the University of Pittsburgh School of Medicine. The vaccine activates the immune system to target a defective protein which is prevalent in colorectal cancer tissue and other precancerous tissues. Researchers hope, if proven successful, the vaccine may eliminate the need for repeated colon screenings in high-risk patients. These patients tend to have multiple precancerous polyps, called advanced adenomas, in their intestines. Routine colonoscopies look for signs of recurrence of the polyps.

Read the rest of this entry »

While overall colorectal cancer rates are steadily decreasing, colorectal cancer rates among younger patients are on the rise, according to data collected from the 13 Surveillance, Epidemiology, and End Results (SEER) cancer registries nationwide and studied by the American Cancer Society.

Read the rest of this entry »

People who suffer from chronic kidney disease may be able to ward off dialysis by taking a daily dose of baking soda, according to researchers from he Department of Renal Medicine and Transplantation at the William Harvey Research Institute Barts, and the London NHS Trust in London.

Read the rest of this entry »

The elderly and those with certain chronic health conditions are at greater risk of suffering from complications following colonoscopies, according to a study conducted by researchers from National Cancer Institute and the University of North Carolina. The study, which was published last month in the Annals of Internal Medicine, looked at data from 53,220 Medicare beneficiaries aged 66 to 95 who underwent colonoscopy between 2001 and 2005.

Read the rest of this entry »

On December 11, 2008, the Food and Drug Administration (FDA) issued a safety alert calling for a black box warning on prescription oral sodium phosphate (OSP) products used to prepare the bowel prior to colonoscopies following reports of a serious form of kidney injury in patients who had taken OSP products.

The black box warning fell on Salix  Pharmaceuticals’ prescription OSP brands Visicol and Osmo Prep, and serious warning was placed on over-the-counter OSP products such as Fleet Phospho-soda and Fleet Accu-Prep. The serious adverse event that was occurring in patients repeatedly over the years was a serious form of kidney injury now known as acute phosphate nephropathy.

Read the rest of this entry »